Skip to main content
. Author manuscript; available in PMC: 2013 Jul 24.
Published in final edited form as: J Nat Prod. 2012 Feb 8;75(3):311–335. doi: 10.1021/np200906s
•New Approved Drugs: With all source categories (Figure 1)
•New Approved Drugs: By source/year (Figure 2)
•Sources of all NCEs: Where four or more drugs were approved per medical indication (Table 1), with listings of diseases with < 3 approved drugs
•Sources of Small-Molecule NCEs: All subdivisions (Figure 3)
•Sources of Small-Molecule NCEs: By source/year (Figure 4)
•Percent N/NB/ND: By year (Figure 5)
•Total Small Molecules: By year (Figure 6)
•Antibacterial Drugs: Generic and trade names, year, reference and source (Table 2)
•Antifungal Drugs Generic and trade names, year, reference and source (Table 3)
•Antiviral Drugs Generic and trade names, year, reference and source (Table 4)
•Antiparasitic Drugs Generic and trade names, year, reference and source (Table 5)
•Antiinfective Drugs All molecules, source and numbers (Table 6)
•Antiinfective Drugs Small molecules, source and numbers (Table 7)
•Anticancer Drugs Generic and trade names, year, reference and source (Table 8; Figure 7)
•All Anticancer Drugs (very late 1930s-12/2010) Generic and trade names, year, reference and source Table 9; Figures 8, 9)
•Antidiabetic Drugs Generic and trade names, year, reference and source (Table 10)